Billions of dollars have been spent on digital diabetes solutions, all promising better outcomes and lower healthcare costs. Yet, research shows many of the most widely used programs today fall short. Low engagement, modest results, and rising costs are leaving payers and patients behind.
This latest white paper, The Cost of Engagement Failure, breaks down why today's leading digital diabetes platforms miss the mark, and how innovative approaches are changing the game by prioritizing engagement and moving from reactive diabetes support to proactive glucose insights to revolutionize digital diabetes care as we know it.